Reduction and Escalation in the Dose of Sunitinib Were Adequately Effective against Gastrointestinal Stromal Tumor of the Small Intestine

We herein report the first case in which an escalated dose of sunitinib was effective, even after dose reduction. A 64-year-old man with gastrointestinal stromal tumor of the small intestine discontinued adjuvant imatinib because of interstitial pneumonia. After two years, peritoneal recurrence was...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Intern Med
Auteurs principaux: Ogata, Misato, Satake, Hironaga, Ogata, Takatsugu, Hatachi, Yukimasa, Hara, Shigeo, Hirota, Seiichi, Yasui, Hisateru
Format: Artigo
Langue:Inglês
Publié: The Japanese Society of Internal Medicine 2019
Sujets:
Case Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6911760/
https://ncbi.nlm.nih.gov/pubmed/31327822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.2806-19
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires